Omega Funds
Life Sciences Venture CapitalBoston, United StatesSee on the mapomegafunds.com
Health specialist
biotechlife sciencesoncologyimmunologyrare diseasesprecision medicine
Omega Funds is an investment firm that invests in founders, products and platforms across therapeutic areas, including oncology, immunology, rare diseases and precision medicine.
- 3
- Portfolio companies on reccy
- 1
- Hiring now
- 1
- Open roles in the portfolio
- Jan 2026
- Latest portfolio round
Hiring now in the portfolio1
Apply on each company's sitePortfolio on reccy3
From company funding recordsCompanyRound backedOpen roles
Their companies, round by round
From company funding records- XII MedicalUnion City, CA
Neuromodulation
- Aug 2024Series B · $45MLed
- May 2022Series A · $30M
- Spiro-medicalIrvine, CA
Neuromodulation
- Jan 2026Series A · $67MLed
- Sep 2023Seed · $500KLed
- SonivieRosh Ha'ayin, Israel
- Jan 2023Series C · $60M
- Oct 2021Venture Round · $150K
- Nov 2015Seed · $2.5M
Rounds marked Led list Omega Funds as a lead investor; the rest are the company's other funding.
Recent rounds in the portfolio
- Jan 2026
Spiro-medical · Series A $67MLead
With Andera Partners, Northern Light Venture Capital, Supernova Invest, Sherpa Healthcare Partners, HSG, Hero Inc
- Aug 2024
XII Medical · Series B $45MLead
With Intuitive Ventures
- Sep 2023
Spiro-medical · Seed $500KLead
Portfolio in the news
From the Cortex · last 12 months- Oct 2026Spiro Medical Begins Trial of Neuromodulation for Asthma
Spiro-medical · Articles | Neurofounders
- Oct 2026
- Feb 2026Mark Wong Appointed Director of Mechanical Engineering at XII Medical
XII Medical · XII Medical on LinkedIn